Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1972 Nov;46(3):386-94.
doi: 10.1111/j.1476-5381.1972.tb08135.x.

The effects of some phosphodiesterase inhibitors on the conductance of the perfused vascular beds of the chloralosed cat

The effects of some phosphodiesterase inhibitors on the conductance of the perfused vascular beds of the chloralosed cat

T C Hamilton. Br J Pharmacol. 1972 Nov.

Abstract

1. The vasoactivity of a number of phosphodiesterase inhibitors in the auto-perfused splanchnic region and hindquarters of the cat have been investigated.2. Theophylline, dipyridamole and 4-(3,4-dimethoxybenzyl)-2-imidazolidinone (Ro 7-2956) and its analogues were more potent vasodilators in the splanchnic region than in the hindquarters, whereas papaverine was a potent vasodilator in both these vascular beds.3. The vasodilator response to the phosphodiesterase inhibitors in the splanchnic region and hindquarters was not susceptible to beta-adrenoceptor blockade.4. Infusion of dibutyryl cyclic AMP into the superior mesenteric artery increased vascular conductance of the splanchnic region. This effect was enhanced by Ro 20-1724 in doses below those in which this compound affected conductance.5. These results are consistent with the hypothesis that accumulation of cyclic AMP in vascular smooth muscle mediates the vasodilator response to phosphodiesterase inhibitors.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Physiol. 1967 Jan;188(2):159-76 - PubMed
    1. Am J Physiol. 1968 Jan;214(1):107-14 - PubMed
    1. J Pharm Pharmacol. 1968 May;20(5):368-72 - PubMed
    1. Pharmacol Rev. 1968 Sep;20(3):117-96 - PubMed
    1. Pharmacol Rev. 1968 Dec;20(4):197-272 - PubMed

MeSH terms